Global Gene Delivery System Market Growth (Status and Outlook) 2023-2029

Global Gene Delivery System Market Growth (Status and Outlook) 2023-2029

Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
LPI (LP Information)' newest research report, the “Gene Delivery System Industry Forecast” looks at past sales and reviews total world Gene Delivery System sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Delivery System sales for 2023 through 2029. With Gene Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Delivery System industry.
This Insight Report provides a comprehensive analysis of the global Gene Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Delivery System and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Delivery System.
The global Gene Delivery System market size is projected to grow from US$ 6923.7 million in 2022 to US$ 40340 million in 2029; it is expected to grow at a CAGR of 28.6% from 2023 to 2029.
Gene Delivery System is widely used for Neurological Diseases, Cancer, etc. The Neurological Diseases occupied about 60% of market share, the cancer occupied about 35%.
North America is the largest consumption place, with a consumption market share nearly 62% in 2019. Following North America, Europe and Asia-Pacific occupied about 35% revenue market share in 2019.
Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen,Spark Therapeutics, Akcea Therapeutics, bluebird bio, Sunway Biotech, SIBIONO, AnGes, Orchard Therapeutics, Human Stem Cells Institute and etc. are the leaders of the industry. In 2019,top 3 companies occupied over 80% of revenue market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Delivery System market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Viral Gene Delivery System
Non-viral Gene Delivery System
Segmentation by application
Neurological Diseases
Cancer
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute

Please note: The report will take approximately 2 business days to prepare and deliver.